Latest AI and machine learning research in depression for healthcare professionals.
Although psychotherapy is a well-established treatment for depression and anxiety, chatbot-delivered psychotherapy is an emerging field that has yet to be explored in depth. This review aims to (a) examine the effectiveness of chatbot-delivered psychotherapy in improving depressive symptoms among adults with depression or anxiety, and (b) evaluate the preferred features for the design of chatbot-d...
BACKGROUND: Multiple treatments are effective for major depressive disorder (MDD), but the outcomes of each treatment vary broadly among individuals. Accurate prediction of outcomes is needed to help select a treatment that is likely to work for a given person. We aim to examine the performance of machine learning methods in delivering replicable predictions of treatment outcomes.
Insomnia is a common sleep disorder characterized by difficulties initiating sleep, maintaining sleep and/or early-morning awakenings. Hyperarousal is...
OBJECTIVE: Previous studies have shown that excess weight (including obesity and overweight) can increase the risk of cardiovascular, cerebrovascular ...
This narrative review aims to provide an overview of the main Machine Learning (ML) techniques and their applications in pharmacogenetics (such as ant...
Considering human brain disorders, Major Depressive Disorder (MDD) is seen as a lethal disease in which a person goes to the extent of suicidal behavi...
Drug repurposing or repositioning has been well-known to refer to the therapeutic applications of a drug for another indication other than it was orig...
BACKGROUND AND AIM: Berg. (Myrtaceae) present several pharmacological actions, but there are no reports on its antidepressant-like potential. This st...
Socially engaging robots have been increasingly applied to alleviate depressive symptoms and to improve the quality of social life among different pop...
Social scientists and psychologists take interest in understanding how people express emotions and sentiments when dealing with catastrophic events su...
Depression symptom heterogeneity limits the identifiability of treatment-response biomarkers. Whether improvement along dimensions of depressive sympt...
Precise remote evaluation of both suicide risk and psychiatric disorders is critical for suicide prevention as well as for psychiatric well-being. Usi...
In psychiatry, compared to other medical fields, the identification of biological markers that would complement current clinical interview, and enable...
Minnesota Multiphasic Personality Inventory-2 (MMPI-2) is a widely used tool for early detection of psychological maladjustment and assessing the leve...
Depression is a severe psychological condition that affects millions of people worldwide. As depression has received more attention in recent years, i...
Advances in artificial intelligence and machine learning have fueled growing interest in the application of predictive analytics to identify high-risk...
The habenula is one of the most important brain regions for investigating the etiology of psychiatric diseases such as major depressive disorder (MDD)...
In-needle microextraction consists of the confinement of the sorbent, by coating or packing, inside a metallic needle. The size of the needles reduces...
OBJECTIVES: Antidepressants are first-line treatments for major depressive disorder (MDD), but 40-60% of patients will not respond, hence, predicting ...
Suicidal thoughts and behaviours are prevalent among college students. Yet little is known about screening tools to identify students at higher risk. ...